4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamide has been researched along with trichostatin a in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Brosch, G; Gerhäuser, C; Jung, M; Kölle, D; Loidl, P; Scherf, H | 1 |
| Atadja, P; Bair, KW; Cornell, WD; Green, MA; Howell, KL; Jung, M; Kwon, P; Remiszewski, SW; Sambucetti, LC; Trogani, N; Walker, H | 1 |
| Belvedere, S; Miller, TA; Witter, DJ | 1 |
| Brauch, C; Dequiedt, F; Heltweg, B; Jung, M; Marshall, BL; Nishino, N; Verdin, E; Yoshida, M | 1 |
| Dickmanns, A; Eliseeva, E; Ficner, R; Jung, M; Saunders, L; Schäfer, S; Schlimme, S; Schwienhorst, A; Sippl, W; Strasser, A; Velena, A; Verdin, E | 1 |
| Cheng, F; Dong, N; Huang, J; Jiang, X; Li, J; Lin, P; Liu, M; Lu, W; Ouyang, P; Tang, Y; Wu, D; Wu, Z; Xu, Z; Yao, X; Zeng, M; Zhang, C; Zou, S | 1 |
| Ballante, F; Marshall, GR; Reddy, DR; Zhou, NJ | 1 |
| Brindisi, M; Brogi, S; Butini, S; Campiani, G; Gemma, S; Saraswati, AP | 1 |
| Chiba, DE; Dos Santos, JL; Lopes, JR | 1 |
2 review(s) available for 4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamide and trichostatin a
| Article | Year |
|---|---|
Histone deacetylase inhibitors.
Topics: Animals; Antineoplastic Agents; Binding Sites; Crystallography, X-Ray; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Humans; Models, Molecular; Sequence Alignment; Structure-Activity Relationship | 2003 |
HIV latency reversal agents: A potential path for functional cure?
Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Molecular Structure; Virus Latency | 2021 |
7 other study(ies) available for 4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamide and trichostatin a
| Article | Year |
|---|---|
Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation.
Topics: Animals; Cell Differentiation; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Mice; Models, Molecular; Structure-Activity Relationship; Tumor Cells, Cultured | 1999 |
Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates.
Topics: Antineoplastic Agents; Benzamides; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Hydroxylamines; Models, Molecular; Promoter Regions, Genetic; Structure-Activity Relationship; Tumor Cells, Cultured | 2002 |
Subtype selective substrates for histone deacetylases.
Topics: Animals; HeLa Cells; Histone Deacetylases; Humans; In Vitro Techniques; Liver; Lysine; Rats; Recombinant Proteins; Sirtuin 1; Sirtuins; Stereoisomerism; Structure-Activity Relationship; Substrate Specificity | 2004 |
Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs).
Topics: Blotting, Western; Cell Line, Tumor; Cell Proliferation; Computer Simulation; Crystallography, X-Ray; Enzyme Inhibitors; Histone Deacetylase 1; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Phenylalanine; Protein Binding; Tubulin | 2008 |
Drug Repurposing of Histone Deacetylase Inhibitors That Alleviate Neutrophilic Inflammation in Acute Lung Injury and Idiopathic Pulmonary Fibrosis via Inhibiting Leukotriene A4 Hydrolase and Blocking LTB4 Biosynthesis.
Topics: Acute Lung Injury; Animals; Epoxide Hydrolases; Female; Histone Deacetylase Inhibitors; Idiopathic Pulmonary Fibrosis; Leukotriene B4; Mice; Mice, Inbred C57BL; Neutrophils | 2017 |
Structural insights of SmKDAC8 inhibitors: Targeting Schistosoma epigenetics through a combined structure-based 3D QSAR, in vitro and synthesis strategy.
Topics: Animals; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Histone Deacetylases; In Vitro Techniques; Molecular Docking Simulation; Molecular Structure; Quantitative Structure-Activity Relationship; Schistosoma mansoni | 2017 |
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases.
Topics: Animals; Biomarkers; Cell Line; Epigenesis, Genetic; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Mice; Protein Processing, Post-Translational; Rare Diseases | 2020 |